Collaboration and Distribution Agreement Sample Contracts

AutoNDA by SimpleDocs
COLLABORATION AND DISTRIBUTION AGREEMENT
Collaboration and Distribution Agreement • November 8th, 2022 • Silverback Therapeutics, Inc. • Pharmaceutical preparations • New York

THIS COLLABORATION AND DISTRIBUTION AGREEMENT (the “Agreement”) is entered into as of March 1st, 2021 (the “Effective Date”), by and between ARS PHARMACEUTICALS, INC., a Delaware corporation (“ARS”), having an address of 3525 Del Mar Heights Rd., #855, San Diego, CA 92130, U.S., and Pediatrix Therapeutics, a Cayman corporation (“Pediatrix”), having a registered office at Aequitas International Management Ltd., Grand Pavilion Commercial Center, Suite 24, 802 West Bay Road, P.O. Box 10281, Grand Cayman KY1-1003, Cayman Island. ARS and Pediatrix may be referred to herein individually as a “Party” or collectively as the “Parties”.

COLLABORATION AND DISTRIBUTION AGREEMENT
Collaboration and Distribution Agreement • October 26th, 2010 • SemiLEDs Corp • Semiconductors & related devices • California

This Collaboration and Distribution Agreement (the “Agreement”) is entered into effective as of April 18, 2007 (the “Effective Date”) by and between INTEMATIX CORPORATION, a California corporation and its Affiliates (“Intematix”), and SEMILEDS CORPORATION, a Delaware corporation and its Affiliates (“SemiLEDs”).

TITIJAYA LAND BERHAD ("TITIJAYA" OR "COMPANY")
Collaboration and Distribution Agreement • August 14th, 2020

COLLABORATION AND DISTRIBUTION AGREEMENT BETWEEN TITIJAYA RESOURCES SDN. BHD., A WHOLLY OWNED SUBSIDIARY OF TITIJAYA, AND RUBBEREX CORPORATION (M) BERHAD (“AGREEMENT”)

Collaboration and Distribution Agreement (Roflumilast in the USA) By and between Nycomed GmbH Byk Gulden-Strasse 2 78467 Konstanz Federal Republic of Germany and Forest Laboratories Holdings Limited Milner House Hamilton, HM11 Bermuda
Collaboration and Distribution Agreement • February 9th, 2012 • Forest Laboratories Inc • Pharmaceutical preparations

This collaboration and distribution agreement, dated as of the 7th day of August, 2009 (the “Effective Date”), relating to the pharmaceutical compound roflumilast is being entered into by and between Nycomed GmbH, a corporation organized and existing under the laws of Germany and having its principal office at Byk-Gulden-Strasse 2, 78467 Konstanz, Federal Republic of Germany, and Forest Laboratories Holdings Limited, a corporation organized and existing under the laws of the Republic of Ireland, with its principal offices located at Milner House, 18 Parliament Street, Hamilton, HM11, Bermuda, and a wholly-owned subsidiary of Forest Laboratories, Inc.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!